First-in-human feasibility study of a portable low-field pulsed-gradient-free MR device in acute stroke

We conducted the first-in-human evaluation of a novel portable low-field 0.1 T pulsed-gradient-free magnetic resonance (MR) device (~ 100 kg) that acquires regional MR biomarkers for bedside stroke assessment. We aimed to evaluate its safety, tolerability and feasibility in acute stroke. This single-centre non-randomised observational cohort study prospectively recruited healthy controls and consecutive stroke patients within 72-h of hospital presentation. Participants underwent conventional 1.5–3 T MRI and two consecutive device scans (DWI, T2). The primary outcomes were feasibility with the proportion of scans where an interpretable signal-to-noise ratio (SNR) was obtained, safety, and tolerability via survey. Forty of forty-nine participants with acute stroke (34 ischemic and 6 hemorrhagic) had successful scans; median age 71 (years[IQR 58.5–76.5]); median NIHSS 4.5 [IQR 2.0–12.0]) and 20 healthy controls were enrolled. No device-related safety concerns were identified, and the scanner was generally well tolerated. SNR ≥ 3 for algorithm-based analysis were obtained in 36/40 (90.0%) stroke participants and 12/40 (30.0%) achieved the higher threshold for heatmap visualisation (SNR ≥ 12). This first-in-human study demonstrates the safety, tolerability, and technical feasibility of operating the device within an inpatient stroke workflow and generate interpretable MR-derived signals in most patients. These findings justify larger prospective studies to evaluate diagnostic performance and clinical implementation.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-18
DOI
https://doi.org/10.1038/s41598-026-80754-0
Primary Topic
Advanced MRI Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

First-in-human feasibility study of a portable low-field pulsed-gradient-free MR device in acute stroke

Sergei I. Obruchkov, James L. Barker, Javier M. Romero, Leonid P. Churilov et al.
2 links
Scientific Reports
Advanced MRI Techniques and Applications
article

First-in-human feasibility study of a portable low-field pulsed-gradient-free MR device in acute stroke

Sergei I. Obruchkov, James L. Barker, Javier M. Romero, Leonid P. Churilov, David S. Liebeskind, Samantha Rivet, Geoffrey Alan Donnan, Stephen M. Davis, Paul D. Teal, Oshi Swarup, Dion Thomas, Yu‐Chieh Tzeng, Bruce C.V. Campbell, Mark William Parsons, J I Goldstein, Amy McDonald, Laura Mulligan, Sean Pierce, Osama O. Zaidat, Peter Anderyas, Flynn Stilwill, Tyson Moed, Anne W. Alexandrov, Andrei V. Alexandrov, Kern Cowell, Gerard Loquet
article en

Abstract

We conducted the first-in-human evaluation of a novel portable low-field 0.1 T pulsed-gradient-free magnetic resonance (MR) device (~ 100 kg) that acquires regional MR biomarkers for bedside stroke assessment. We aimed to evaluate its safety, tolerability and feasibility in acute stroke. This single-centre non-randomised observational cohort study prospectively recruited healthy controls and consecutive stroke patients within 72-h of hospital presentation. Participants underwent conventional 1.5–3 T MRI and two consecutive device scans (DWI, T2). The primary outcomes were feasibility with the proportion of scans where an interpretable signal-to-noise ratio (SNR) was obtained, safety, and tolerability via survey. Forty of forty-nine participants with acute stroke (34 ischemic and 6 hemorrhagic) had successful scans; median age 71 (years[IQR 58.5–76.5]); median NIHSS 4.5 [IQR 2.0–12.0]) and 20 healthy controls were enrolled. No device-related safety concerns were identified, and the scanner was generally well tolerated. SNR ≥ 3 for algorithm-based analysis were obtained in 36/40 (90.0%) stroke participants and 12/40 (30.0%) achieved the higher threshold for heatmap visualisation (SNR ≥ 12). This first-in-human study demonstrates the safety, tolerability, and technical feasibility of operating the device within an inpatient stroke workflow and generate interpretable MR-derived signals in most patients. These findings justify larger prospective studies to evaluate diagnostic performance and clinical implementation.

Scientific Reports
University of Southern California (US), The University of Sydney (AU), Mercy St. Vincent Medical Center (US), The Royal Melbourne Hospital (AU), Harvard University (US), University of Tennessee Health Science Center (US), The University of Melbourne (AU), Westmead Hospital (AU), Massachusetts General Hospital (US), University of Arizona College of Medicine- Phoenix (US)
Australian Government, Medical Research Future Fund
Good health and well-being
Advanced MRI Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon